Antipsychotics and Weight Gain
Host: Leslie P. Lundt, MD Guest: Gualberto Ruano, MD, PhD One-third of patients suffering from schizophrenia develop diabetes as a direct result of treatment. In the future, we may be able to use pharmacogenomics to determine which antipsychotic would be the safest for any given patient. Is the future here? Dr Ruaño joins host Dr. Leslie Lundt to discuss his recent work in this area.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Clinician's Roundtable?
This episode is 13 minutes long.
When was this Clinician's Roundtable episode published?
This episode was published on October 29, 2007.
Can I download this Clinician's Roundtable episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.